ECCMID 2024 – LEX Diagnostics

Home
About us
- Leadership team
- Advisors
Technology
Careers
News & Events
Contact

Press release

May 28, 2024

ECCMID 2024

The LEX platform is not currently approved for clinical use in any jurisdiction but when approved it will enhance clinical decision making and improve treatment for respiratory infections through fast, accurate and easy-to-use point-of-care testing.

PRIVACY POLICY

TERMS & CONDITIONS

COOKIES

LEX Diagnostics Limited
Melbourn Science Park
Melbourn, SG8 6EE
UK

Registered Office: TTP Campus, Melbourn, SG8 6HQ, UK
Registered in England & Wales no. 12455716
VAT No 343 2560 21